Intra-Cellular: 3Q Earnings Snapshot
NEW YORK (AP) _ Intra-Cellular Therapies Inc. (ITCI) on Tuesday reported a loss of $34.9 million in its third quarter.
The New York-based company said it had a loss of 63 cents per share.
The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 86 cents per share.
Intra-Cellular shares have decreased 16% since the beginning of the year. The stock has declined 48% in the last 12 months.